TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: global encrustation rate of stent ends
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement from functional anosmia to healthy normosmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in calcium cation concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean arterial pressures <65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean inflammatory acne lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acne erythema grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamstring strength deficit on the operated leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps strength deficit on the operated leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Single leg hop test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pinprick sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adverse events during the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Virological success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: SWN-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total daily protein intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MPTA and LDFA correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Varus and valgus angle correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain complaint
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: ∆KOOS4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆WOMAC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complications and reoperation rates
Endpoint domain: Adverse events/effects
Primary endpoint: Major bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EHI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-assessment improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of TB awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive attitudes towards TB
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self‐preventive care among TB patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-observer reliability of classification systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-observer reliability of classification systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eating vegetables or salad less than once a day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Being a daily smoker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Being physically active for less than 3 days per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased pulse wave velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Increased total collagen contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AROM of shoulder abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle activity of maximum voluntary isometric contraction (MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: compensatory scapular muscle activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital readmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serious postoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 15-m walking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maturation rates at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Primary patency rates at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of wound healing issues and infection
Endpoint domain: Adverse events/effects
Primary endpoint: Stone expulsion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean difference of the HDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mTSS response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare utilization (outpatient physician, laboratory, and radiology visit-days)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: infant hospital length of stay (LOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ureteral obstruction (UAS) occurrences
Endpoint domain: Adverse events/effects
Primary endpoint: 12-month target lesion failure (TLF)
Endpoint domain: Mortality/survival
Primary endpoint: Genetic diversity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain medication consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of LF3-4 values in CRC diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced pregnancy weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced triglyceridemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in ratio of forced expiratory volume in 1 s to forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: average amount of sputum among 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Infarct zone circumferential strain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete healing time of partial-thickness burns and donor sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased markers of T‐cell and monocyte/macrophage activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median time to initial HAQ‐DI score response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to initial FACIT‐F total score response
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: DASH diet quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum protein concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: suction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progress during intervention phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in adolescent depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ameliorated sensorimotor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enhanced cutaneous sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in KHQ scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perception of improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of lymph node dissections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: exposure at initial time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of DA
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scapular posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Y-Balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Quarter Y-Balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in oral PMN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of knowledge at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: muscle mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of RS on clinical outcomes in MBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary nitrite levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harvard Step Test fitness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Benefits from TD-CBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of clinical stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of clinical depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary tract infections prevention
Endpoint domain: Adverse events/effects
Primary endpoint: Sample classification performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to COVID negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma sodium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PQ-interval lengthening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility and acceptability of direct recruitment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attendance rates and data completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: First insertion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to identify the needle puncture site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of parturients who required needle redirections
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of eyes gaining ≥15 letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in central foveal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from surgery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total analgesic consumption in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total paravertebral bupivacaine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technical difficulties and complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urine toxicology‐confirmed self‐reported abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue required by day 84
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reversible corneal haze
Endpoint domain: Adverse events/effects
Primary endpoint: Palpation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECT thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance for continuous surveillance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dropout rates for testing methods
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of SARS-CoV-2 infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Risk of fetal or neonatal death or serious neonatal morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Range of motion (ROM) at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events of severe grade
Endpoint domain: Adverse events/effects
Primary endpoint: 12-month freedom from AF/atrial tachycardia/atrial flutter-recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety endpoints at 10-day and 12-month
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of abstinence from alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: D-lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endogenous progesterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinical improvement on day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative RT-PCR result on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose of analgesic required in the first 8 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction with the block
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain experienced compared with group L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side branch stent expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: quality of life effects
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in CADSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall trial satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Metabolic Syndrome (MetSy) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attendance at classes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Home practice frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helpfulness rating of classes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication about sexual issues
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cigarette abstinence rate
Endpoint domain: Mortality/survival
Primary endpoint: Attention and memory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-perceived benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time of dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dose of tramadol used as rescue analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total cost of analgesia used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CRPC-FS (Castration-Resistant Prostate Cancer-Free Survival)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ANL improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BNL improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STI self-screening completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of unprotected sex acts
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Refusal of sex if partner was not tested
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes of soft tissue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of fluorescence per mm² in the DEJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cumulative dose of paracetamol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival outcomes in patients with ALS
Endpoint domain: Mortality/survival
Primary endpoint: LIBRA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: intramuscular glycogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Full Scale IQ (FSIQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effectiveness of AI-guided PVI compared to CF-guided PVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of AI-guided PVI compared to CF-guided PVI
Endpoint domain: Adverse events/effects
Primary endpoint: CTO lesion length >20 mm as a predictor of procedural failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: instant arthroscopy performance total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cartilage injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labor inductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Small for gestational age babies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Median cumulative progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: duration of resolution of diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Downregulation of ceramides, phospholipids, and triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PRU reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of HM occurring after GAC surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate recovery after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean BoP (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score for treatment pain/discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful treatment rate at 12-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent concerns about hearing loss
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feeding intolerance incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse fetal and neonatal outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: steps accrued
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: light-intensity activity duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean proportion of days injecting opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first opioid injection post-release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deterioration in gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain score at 120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: angulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum distance from the ideal position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of appropriate tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of tests ordered per panel
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: diagnostic error
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of segments with inadequate FT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: median FT density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: homogeneity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Skeletal muscle microvascular blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes